New Pfizer chief's salary set at $1.7M; EMA: Possible endotoxins in three Baxter products;

@FiercePharma: Amid politicized debate, Roche appeals Avastin choice. News | Follow @FiercePharma

> Pfizer will pay its new chief executive Ian Read a base salary of $1.7 million plus a bonus for 2011. Report

> The European Medicines Agency said current stocks of Baxter International's peritoneal dialysis solutions--Dianeal, Extraneal, and Nutrineal--should be replaced because of the possibility of endotoxin contamination. Article

> Generic drug companies, led by Teva Pharmaceutical Industries, would face fewer factory inspections and save as much as a year developing products in exchange for paying fees for the first time under a proposal the FDA is evaluating. Item

> German scientists have found a new genetic basis for why some patients respond better to the anti-clotting medicine Plavix that could be used to test people before they get the world's second-biggest drug. Story

> Bioton stock jumped the most in more than a year after signing a deal through which GlaxoSmithKline will distribute the Polish company's insulin in Russia. Report

> The chief executive of Sanofi Aventis says he is "not surprised'' that fewer than 1 percent of Genzyme stockowners accepted his company's $69-a-share tender offer this fall, but he gave no indication the French drugmaker was prepared to sweeten its bid. News

> U.K. regulators asked Indian pharmaceutical firm Ranbaxy to recall three batches of its cholesterol tablet Pravastatin on failure to update safety warnings in its information leaflets. Item

> Pharmaceuticals robbed by gunmen were recovered by police after hidden tracking devices led authorities to two stolen vans, according to reports. Story

> Novozymes is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA, boosting its presence in the fast-growing agricultural biotech segment. Report

Biotech News

@FierceBiotech: Cephalon co-founder, CEO Frank Baldino dies at 57. Story | Follow @FierceBiotech

 @JohnCFierce: Nymox shares soar 35 percent after it announces $13M upfront on late-stage BPH pact. Report | Follow @JohnCFierce

> Sanofi, Avila ink $800M oncology drug development pact. News 

> BMS, Oncolys ink HIV pact. Article

> Gilead buys Arresto for $225M. Story

> Pfizer ($PFE) signs separate agreements with Lpath, Phylogica. News 

Biotech IT News

> App connects dictation, transcription via iPhone. News 

> Study: Brazil bests India for subject recruitment. Report 

> GSK opts for BioClinica IVR system across trials. Item

> Program grows clinical, translational researchers. Story 

> Imaging can lead to investigator ethical dilemma. Article 

> PROs join recruitment in social net benefit. News

And Finally... Drugstores, supermarkets and some doctors' offices are slashing prices or offering other kinds of deals on flu vaccine this year amid weaker-than-expected demand. Report